Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
Copyright policy )Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
Adult, Male, Antimetabolites, Antineoplastic, Antimetabolites, Prognosi, DNA-Binding Protein, Myelodysplastic Syndrome, BCL2L10; TET2; 5-azacytidine; myelodysplastic syndromes, Dioxygenases, Antimetabolites, Antineoplastic; Male; Prognosis; Retrospective Studies; Azacitidine; Survival Rate; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Mutation; Female; Risk Factors; DNA-Binding Proteins; Humans; DNA Methylation; Proto-Oncogene Proteins; Aged; Adult; Myelodysplastic Syndromes, Retrospective Studie, Risk Factors, Proto-Oncogene Proteins, Humans, Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; DNA-Binding Proteins; Female; Humans; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Risk Factors; Survival Rate; DNA Methylation, Aged, Retrospective Studies, Proto-Oncogene Protein, Risk Factor, DNA Methylation, Middle Aged, Prognosis, Antineoplastic, DNA-Binding Proteins, Survival Rate, Settore MED/15 - MALATTIE DEL SANGUE, Proto-Oncogene Proteins c-bcl-2, Myelodysplastic Syndromes, Mutation, Azacitidine, Female, Human
Adult, Male, Antimetabolites, Antineoplastic, Antimetabolites, Prognosi, DNA-Binding Protein, Myelodysplastic Syndrome, BCL2L10; TET2; 5-azacytidine; myelodysplastic syndromes, Dioxygenases, Antimetabolites, Antineoplastic; Male; Prognosis; Retrospective Studies; Azacitidine; Survival Rate; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Mutation; Female; Risk Factors; DNA-Binding Proteins; Humans; DNA Methylation; Proto-Oncogene Proteins; Aged; Adult; Myelodysplastic Syndromes, Retrospective Studie, Risk Factors, Proto-Oncogene Proteins, Humans, Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; DNA-Binding Proteins; Female; Humans; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Risk Factors; Survival Rate; DNA Methylation, Aged, Retrospective Studies, Proto-Oncogene Protein, Risk Factor, DNA Methylation, Middle Aged, Prognosis, Antineoplastic, DNA-Binding Proteins, Survival Rate, Settore MED/15 - MALATTIE DEL SANGUE, Proto-Oncogene Proteins c-bcl-2, Myelodysplastic Syndromes, Mutation, Azacitidine, Female, Human
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).40 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!